Columnist Dagmar Munn has managed the shift to a rollator, scooter, and other assistive devices that help her live a better ...

The results of CardinALS showed utreloxastat failed to meet its main and secondary goals, including several disease-related ...

Neuralink's brain-computer interface will be tested in Canada, with Toronto's University Health System seeking patients for ...

The Phase 1 trial ANQUR, now testing two new doses of the ALS therapy QRL-201, is enrolling patients at 12 sites in Canada ...

Scientists studied 188 people related to someone with ALS caused by a C9ORF72 mutation to identify markers of disease risk in ...

Columnist Kristin Neva recognizes the distinction between being thankful "in" a bad situation rather than "for" a bad situation.